These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38587252)

  • 1. Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis.
    Hanami Y; Yamamoto T
    J Dermatol; 2024 Sep; 51(9):e291-e292. PubMed ID: 38587252
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute onset of psoriasis in a patient with atopic dermatitis treated with dupilumab.
    Ferrucci S; Tavecchio S; Berti E; Angileri L
    Clin Exp Dermatol; 2020 Jul; 45(5):625-626. PubMed ID: 32112580
    [No Abstract]   [Full Text] [Related]  

  • 3. Dupilumab-Induced Extrafacial Paradoxical Persistent Erythema in an Atopic Dermatitis Patient.
    Juan-Carpena G; Palazón-Cabanes JC; Bañuls J; Docampo-Simón A; Sánchez-Pujol MJ; Niveiro M; Silvestre JF
    Dermatitis; 2021 Oct; 32(1S):e83-e85. PubMed ID: 34405837
    [No Abstract]   [Full Text] [Related]  

  • 4. Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis.
    Yamane MLM; Belsito DV; Glass LRD
    Orbit; 2019 Oct; 38(5):390-394. PubMed ID: 30628518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.
    Magdaleno-Tapial J; Valenzuela-Oñate C; García-Legaz-Martínez M; Martínez-Domenech Á; Pérez-Ferriols A
    Australas J Dermatol; 2020 May; 61(2):e223-e225. PubMed ID: 31766073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythema induratum of Bazin during successful treatment of atopic dermatitis with dupilumab.
    Zhou C; Su T; Wang Y; Hou Y; Yin Z; Xia J
    Australas J Dermatol; 2024 May; 65(3):e69-e71. PubMed ID: 38421820
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience.
    Simonetti O; Radi G; Diotallevi F; Molinelli E; Rizzetto G; Offidani A
    Clin Exp Dermatol; 2021 Jul; 46(5):939-940. PubMed ID: 33576497
    [No Abstract]   [Full Text] [Related]  

  • 8. Rosacea associated with dupilumab therapy.
    Heibel HD; Hendricks AJ; Foshee JP; Shi VY
    J Dermatolog Treat; 2021 Feb; 32(1):114-116. PubMed ID: 31132923
    [No Abstract]   [Full Text] [Related]  

  • 9. Facial and neck erythema associated with dupilumab treatment: A systematic review.
    Jo CE; Finstad A; Georgakopoulos JR; Piguet V; Yeung J; Drucker AM
    J Am Acad Dermatol; 2021 May; 84(5):1339-1347. PubMed ID: 33428978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of recurrent exit site and tunnel infections caused by atopic dermatitis with dupilumab: A case report.
    Noda R; Ishibashi Y
    Ther Apher Dial; 2022 Feb; 26(1):255-256. PubMed ID: 34018694
    [No Abstract]   [Full Text] [Related]  

  • 11. Onset of Schamberg Disease and Resolution of Alopecia Areata During Treatment of Atopic Dermatitis With Dupilumab.
    Szekely S; Vaccari D; Salmaso R; Belloni-Fortina A; Alaibac M
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):65-66. PubMed ID: 32490817
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and Efficacy of Dupilumab in an Atopic Adolescent With Primary Immune Deficiency.
    Tanner JF; Knutsen AP; Siegfried E
    Dermatitis; 2021 Oct; 32(1S):e91-e92. PubMed ID: 34677168
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports.
    Ferrucci S; Romagnuolo M; Angileri L; Berti E; Tavecchio S
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e303-e304. PubMed ID: 32330323
    [No Abstract]   [Full Text] [Related]  

  • 14. Dupilumab in HIV-positive patients with atopic dermatitis: a long-term follow-up patient and a literature review.
    Avallone G; Trunfio M; Giura MT; Siliquini N; Viola R; Orofino G; Mastorino L; Ortoncelli M; Quaglino P; Ribero S
    Dermatol Online J; 2021 Aug; 27(8):. PubMed ID: 34755964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of conjunctivitis with a conjunctival proliferative lesion in a patient treated with dupilumab for atopic dermatitis.
    Fukuda K; Ishida W; Kishimoto T; Fukushima A
    Allergol Int; 2019 Jul; 68(3):383-384. PubMed ID: 30718036
    [No Abstract]   [Full Text] [Related]  

  • 16. All- trans-retinoic acid-induced erythema nodosum in patients with acute promyelocytic leukemia.
    Kuo MC; Dunn P; Wu JH; Shih LY
    Ann Hematol; 2004 Jun; 83(6):376-80. PubMed ID: 14648024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of atopic keratoconjunctivitis during treatment with dupilumab for atopic dermatitis.
    Cheng J; Jiang L; Morrow NC; Avdic A; Fairley JA; Ling JJ; Greiner MA
    J Am Acad Dermatol; 2021 Jul; 85(1):265-267. PubMed ID: 32956738
    [No Abstract]   [Full Text] [Related]  

  • 18. Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic.
    Hansel K; Patruno C; Antonelli E; Dal Bello G; Napolitano M; Fabbrocini G; Grieco T; Pellacani G; Fargnoli MC; Esposito M; Piras V; Zucca M; Girolomoni G; Stingeni L
    Clin Exp Dermatol; 2022 Jan; 47(1):165-167. PubMed ID: 34309892
    [No Abstract]   [Full Text] [Related]  

  • 19. Angioedema: A potential complication of dupilumab in atopic dermatitis.
    Fritz AL; Lacy FA; Morrell DS
    Pediatr Dermatol; 2021 Jan; 38(1):237-238. PubMed ID: 33099796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic annular erythema-like adult-onset atopic dermatitis successfully treated with dupilumab.
    Liaw TY
    Ital J Dermatol Venerol; 2024 Apr; 159(2):203-205. PubMed ID: 38650501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.